Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2025 Aug 21;13(1):182.
doi: 10.1186/s40478-025-02094-w.

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling

Konstantin Okonechnikov  1   2 , David R Ghasemi  1   2   3   4   5   6 , Daniel Schrimpf  1   7   8 , Svenja Tonn  3 , Martin Mynarek  3   4 , Jan Koster  9 , Till Milde  1   6   10   11 , Tuyu Zheng  1   2 , Philipp Sievers  7   8 , Felix Sahm  1   7   8 , David T W Jones  1   12 , Andreas von Deimling  1   7   8 , Stefan M Pfister  1   2   6   11 , Marcel Kool  1   2   13 , Kristian W Pajtler  1   2   6 , Andrey Korshunov  14   15   16   17
Affiliations
Published Erratum

Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling

Konstantin Okonechnikov et al. Acta Neuropathol Commun. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Annotation onco-plot describing patient histological and molecular characteristics for target ZFTA-RELA ST-EPN tumors with available RNA sequencing data (n = 80). The following abbreviations were used: RT - radiotherapy, LOC - conformal local, CSP - craniospinal, PFS—progression-free survival, CNV—copy number variants. (b) Genomic locations the ZFTA-RELA fusion breakpoints stating the main types of the fusion. c, d) No survival differences were identified between the various ZFTA-RELA fusion types. d) Heatmap of significant differentially expressed genes between ZFTA-RELA fusion type 1 (n = 29) and 2 (n = 16)
Fig. 1
Fig. 1
(a) Annotation onco-plot describing patient histological and molecular characteristics for target ZFTA-RELA ST-EPN tumors with available RNA sequencing data (n = 80). The following abbreviations were used: RT - radiotherapy, LOC - conformal local, CSP - craniospinal, PFS—progression-free survival, CNV—copy number variants. (b) Genomic locations the ZFTA-RELA fusion breakpoints stating the main types of the fusion. c, d) No survival differences were identified between the various ZFTA-RELA fusion types. d) Heatmap of significant differentially expressed genes between ZFTA-RELA fusion type 1 (n = 29) and 2 (n = 16)
See this image and copyright information in PMC

Erratum for

References

    1. Okonechnikov K, Ghasemi DR, Schrimpf D et al (2025) Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling. Acta Neuropathol Commun 13:4. 10.1186/s40478-024-01921-w - PMC - PubMed

Publication types

LinkOut - more resources